Hormone-related claims evidence brief
DIM is a compound formed from cruciferous-vegetable indoles and sold for estrogen metabolism. It is commonly promoted for hormone balance, testosterone support, and physique claims.
DIM has human research in estrogen-metabolism and cancer-adjacent contexts, but that does not translate into proven testosterone, muscle-gain, or physique benefits.
Human DIM trials target estrogen biomarkers or clinical contexts, not testosterone, strength, or physique outcomes.
Trials use specific absorption-enhanced DIM preparations and clinical populations; cruciferous-vegetable metabolites, DIM capsules, and hormone-stack blends are not equivalent.
Hormone-modulation claims need careful wording, and interaction signals around tamoxifen make casual endocrine marketing a trust risk.
Source Drawer
The score reflects evidence that the supplement does its stated job. Some jobs are direct, such as strength, endurance, or recovery; others are indirect, such as sleep, mood, appetite, or health support. A real effect can still receive a cautious practical rating when dose, safety, product quality, or audience fit remain uncertain.
Send the disputed claim, source link, and why it changes the practical verdict. Corrections that materially affect the claim, dose, caveat, or rating are prioritized.
Report a source or rating issue